Asthma affects both the bronchi and the bronchioles. It is not limited to one level of the airway tree. Inflammation, muscle tightening, and excess mucus occur across the full range of conducting airways, from the larger bronchi down to the smallest bronchioles less than 2 mm in diameter. In fact, those tiny peripheral airways are now recognized as the main site of increased airway resistance in asthma and a key driver of symptoms and flare-ups.
How Bronchi and Bronchioles Differ
Your lungs branch like an upside-down tree. Air flows from the windpipe into two main bronchi, which split into smaller and smaller branches called secondary and tertiary bronchi. These eventually taper into bronchioles, defined as airways 1 mm or less in diameter. The structural differences between the two matter for understanding why asthma behaves the way it does.
Bronchi have rings or plates of cartilage in their walls that help hold them open. They’re also lined with mucus-producing goblet cells. As you move deeper into the lungs, the cartilage gradually disappears. Bronchioles have no cartilage at all and no goblet cells. Instead, their walls are mostly smooth muscle wrapped around a thin lining of cells. Without a rigid skeleton to hold them open, bronchioles are far more collapsible. When the smooth muscle contracts or the lining swells, these small airways can narrow dramatically.
Where Asthma Inflammation Occurs
Asthma involves allergic inflammation driven primarily by certain immune cells (a type of white blood cell called eosinophils, along with helper T-cells). This inflammation is present in both the bronchi and the bronchioles. Biopsy studies of asthmatic airways show excess collagen deposited beneath the surface lining of the bronchi, a sign of ongoing tissue remodeling. Meanwhile, eosinophils accumulate not only in the bronchial walls but also deep in the lung, reaching the zones where bronchioles attach to the air sacs.
In fatal asthma cases, pathologists describe glistening mucus plugs scattered throughout both large and small air passages, confirming that the disease process extends across the entire airway tree. Neither the bronchi nor the bronchioles are spared.
Why Small Airways Matter More Than Once Thought
For decades, the bronchioles were called the “silent zone” of the lungs because they were hard to measure with standard breathing tests. In a healthy person, the small airways (those under 2 mm in diameter) contribute only about 10 to 20 percent of total airway resistance. That means significant disease can develop in these tiny passages before a standard spirometry test picks it up.
Newer research has changed the picture considerably. Small airway disease is now recognized as prevalent across all stages of asthma, not just severe cases. Airways under 2 mm are the main site of increased resistance during asthma, and the degree of small airway dysfunction correlates with how well someone’s asthma is controlled, how often they have exacerbations, and how they respond to therapy. In people with severe asthma, small airway closure during flare-ups appears to be a central part of what makes those episodes dangerous.
Studies using challenge tests (where a substance is inhaled to deliberately trigger mild airway narrowing) show something telling: patients start feeling symptoms at a point when resistance in the peripheral airways has already risen significantly, even though standard measures of lung function have barely budged. This suggests the bronchioles are contributing to symptoms well before the larger bronchi show measurable obstruction.
Symptoms Linked to Bronchiolar Involvement
Not all asthma symptoms come equally from all parts of the airway. Inflammation deep in the small airways has distinct clinical consequences. Nocturnal asthma, where symptoms worsen at night, is associated with a nighttime surge of eosinophils in the tissue surrounding the small airways and air sacs. Exercise-induced asthma, heightened sensitivity to triggers, and the late-phase allergic response (symptoms that return hours after the initial exposure) all correlate with distal airway inflammation.
People whose asthma is complicated by smoking or viral respiratory infections also tend to have more prominent small airway disease. Severe, steroid-dependent asthma follows the same pattern. In practical terms, if your asthma is hard to control, wakes you at night, or flares up with exercise despite treatment, small airway involvement is a likely contributor.
How This Affects Treatment
Standard asthma inhalers deliver medication as aerosolized particles, but not all particles reach the same depth in the lungs. To get into the airways at all, particles need to be smaller than 5 micrometers. Particles on the larger end of that range tend to deposit mostly in the upper airways and bronchi. Extra-fine particle formulations, with particles smaller than 2 micrometers, distribute much more uniformly across both the large and small airways.
This distinction has real clinical implications. If inflammation in your bronchioles is driving your symptoms, a standard-particle inhaler may not deliver enough medication to the site that needs it most. Extra-fine particle inhalers are designed to address this gap. Your treatment plan may factor in which parts of your airway tree are most affected, particularly if your asthma has been difficult to manage with conventional inhalers.
Detecting Small Airway Problems
Standard spirometry, the most common breathing test, primarily reflects what’s happening in the larger airways. It can miss early or isolated small airway obstruction. Newer tools like impulse oscillometry offer a way to measure resistance at different depths of the lung without requiring a forceful breath. This test can identify dysfunction in the bronchioles even when spirometry results look normal or near-normal.
Other approaches include measuring closing volume (the lung volume at which small airways begin to collapse during exhalation) and specialized imaging. These methods are becoming more widely available and are particularly useful for patients whose symptoms seem out of proportion to their spirometry results.